Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) EBIT Margin (2016 - 2025)

Historic EBIT Margin for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to 8.45%.

  • CV Sciences' EBIT Margin rose 3800.0% to 8.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.25%, marking a year-over-year increase of 83300.0%. This contributed to the annual value of 13.94% for FY2024, which is 349400.0% down from last year.
  • As of Q3 2025, CV Sciences' EBIT Margin stood at 8.45%, which was up 3800.0% from 3.62% recorded in Q2 2025.
  • CV Sciences' EBIT Margin's 5-year high stood at 138.91% during Q1 2023, with a 5-year trough of 177.96% in Q4 2021.
  • Its 5-year average for EBIT Margin is 27.76%, with a median of 23.39% in 2023.
  • Per our database at Business Quant, CV Sciences' EBIT Margin skyrocketed by 1729800bps in 2023 and then crashed by -1544000bps in 2024.
  • Over the past 5 years, CV Sciences' EBIT Margin (Quarter) stood at 177.96% in 2021, then surged by 69bps to 54.92% in 2022, then soared by 57bps to 23.39% in 2023, then increased by 29bps to 16.63% in 2024, then surged by 49bps to 8.45% in 2025.
  • Its EBIT Margin was 8.45% in Q3 2025, compared to 3.62% in Q2 2025 and 0.31% in Q1 2025.